Article

Tumor relapse-free survival prognosis related consistency between cancer tissue and adjacent normal tissue in drug repurposing for solid tumor via connectivity map

2024-01-03

Abstract excerpt

Traditional drug discovery encounters challenges, including high costs, time-intensive processes, and inherent risks. Drug repurposing emerges as a compelling alternative strategy to identify new indications for investigational or approved drugs, circumventing these obstacles. Among the various drug repurposing methods, the Disease-specific Signature-based Connectivity Map (Cmap) approach is widely utilized. Howev...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d2043e97-753f-5e98-bfc8-ddc31f0e96d8
DOI: 10.1101/2024.01.03.573997

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Tumor relapse-free survival prognosis related consistency between cancer tissue and adjacent normal tissue in drug repurposing for solid tumor via connectivity mapDOI 10.1101/2024.01.03.573997Read

Tumor relapse-free survival prognosis related consistency between cancer tissue and adjacent normal tissue in drug repurposing for solid tumor via connectivity mapSemantic proximity Read

Reversal gene expression assessment for drug repurposing, a case study of glioblastomaSemantic proximity Read

Reversal Gene Expression Assessment for Drug Repurposing, a Case Study of GlioblastomaSemantic proximity Read

Connectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapiesSemantic proximity Read

Identification of important genes and drug repurposing based on clinical-centered analysis across human cancers.Semantic proximity Read

Signature reversion of three disease-associated gene signatures prioritizes cancer drug repurposing candidatesSemantic proximity Read

Prioritization of Potential Drugs Through Pathway-Based Drug Repurposing and Network Proximity AnalysisSemantic proximity Read

A network model for patient-derived drug response in breast cancer integrating multi-omics datasetsSemantic proximity Read

Meta-analysis of preclinical pharmacogenomic studies to discover robust and translatable biomarkers of drug responseSemantic proximity Read

Systematic Meta-Analysis of Published Transcriptomic Prognostic Signatures and Development of a Robust Multi-Cohort Prognostic Classifier for Triple-Negative Breast CancerSemantic proximity Read

Landscape of cancer diagnostic biomarkers from specifically expressed genesSemantic proximity Read

Disease networks and their contribution to disease understanding and drug repurposing: Evolution of the concept, techniques and data sourcesSemantic proximity Read